Filing Details
- Accession Number:
- 0001209191-10-044276
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-27 18:35:35
- Reporting Period:
- 2010-08-25
- Filing Date:
- 2010-08-27
- Accepted Time:
- 2010-08-27 18:35:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380762 | Brian Dorsey | C/O Somaxon Pharmaceuticals, Inc. 3570 Carmel Mountain Road, Suite 100 San Diego CA 92130 | Svp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-08-25 | 615 | $1.23 | 52,535 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-08-25 | 4,385 | $1.23 | 56,920 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-08-25 | 5,000 | $4.99 | 51,920 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-08-25 | 615 | $0.00 | 615 | $1.23 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-08-25 | 4,385 | $0.00 | 4,385 | $1.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,889 | 2018-02-18 | No | 4 | M | Direct | |
| 46,490 | 2019-02-16 | No | 4 | M | Direct |
Footnotes
- Of these shares, 12,500 represent restricted stock units that are vested and 30,000 represent restricted stock units that are unvested.
- This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- 615 shares of common stock subject to the option were vested and exercisable as of August 25, 2010, and appproximately 1,389 shares vest and become exercisable on the first day of each month until June 1, 2011.
- Not applicable.
- 27,726 shares of common stock subject to the option were vested and exercisable as of August 25, 2010, and approximately 2,315 shares vest and become exercisable on the first day of each month until June 1, 2011.
Billionaire Hedge Funds
